Searchable abstracts of presentations at key conferences in endocrinology

ea0081p25 | Adrenal and Cardiovascular Endocrinology | ECE2022

Fibroblast growth factor 21 contributes to adrenal cortex renewal

Diaz Catalan Daniela , Beyhart Arturo , Mora Mireia , Rodrigo Maite , Boswell Laura , Casals Gregori , Alexandra Hanzu Felicia

Objective: After Cushing Syndrome (CS) is cured, up to 70% of patients develop chronic adrenal insufficiency (AI) and hypothalamus-pituitary-adrenal (HPA) axis dysfunction. A long-term treatment with glucocorticoids (GC) is mandatory to overcome AI. However, this treatment implies non-desired complications. Fibroblast growth factor (FGF21), a key regulator of metabolism, has a bidirectional relationship with GC that bypasses the negative feedback of the HPA axis. In this study...

ea0090p106 | Endocrine-related Cancer | ECE2023

Ectopic Cushing syndrome due to a late metastatic recurrence of a salivary gland carcinoma: a new therapeutic approach

Claro Maria , Baste Neus , Casals Gregori , Sanchez Nuria , Mora Mireia , Alexandra Hanzu Felicia

Background: Acinic cell carcinoma of the parotid gland is a rare cancer, and metastatic (M1) disease is uncommon, occurring in around 10% of cases, with ectopic paraneoplastic Cushing being described in only few cases.Clinical case: A 58-year-old woman, with a history of dedifferentiated parotid acinar cell carcinoma, underwent surgery and adjuvant radiotherapy in 2005. In February 2019 the disease recurred with pulmonary, bone and lymph node metastases....

ea0041ep205 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2016

Effects of sex steroids on cardiovascular risk profile in female to male transsexuals with cross-sex hormone treatment

Velazquez Gloria Aranda , Porta Mireia Mora , Hanzu Felicia Alexandra , Vera Josep , Ortega Emilio , Halperin Irene

Introduction: In transsexualism, cross-sex hormone treatment (CHT) both improves and impairs several surrogate cardiovascular risk markers in female to male (FtoM). Few randomized trials on CHT with long follow-up and control group are available, and present evidence is inconsistent. We here assess changes in metabolic and cardiovascular risk after 12 months CHT compared with biological sex in FtoM GID.Methods: Prospective observational study, including ...

ea0063p1179 | Thyroid 3 | ECE2019

Sonographic-pathologic correlation of thyroid nodules: TI-RADS vs EU-TIRADS

Ruiz Sabina , Mora Mireia , Aranda Gloria , Hanzu Felicia , Boswell Laura , Squarcia Mattia , Berenguer Joan , Martinez Daniel , Vidal Oscar , Halperin Irene

Background: Several ultrasound (US) scoring systems have been proposed to provide rules for standardizing risk stratification of thyroid nodules and to select which nodules should have a fine needle aspiration (FNA) biopsy performed. TI-RADS classification is one of the most used in the daily practise. Recently, EU-TIRADS scoring system has been published to simplify the evaluation of thyroid nodules and to integrate previous classifications into a single system. We aimed to c...

ea0041ep733 | Neuroendocrinology | ECE2016

Impaired innate immunity in Cushing’s syndrome: increase CD14+CD16++ monocytes

Velazquez Gloria Aranda , Lopez Cristina , Esteban Yaiza , Mora Mireia , Halperin Irene , Casals Gregori , Ensenat Joaquim , Hanzu Felicia Alexandra

Introduction: Chronic hypercortisolism is marked by an increased cardiovascular risk pattern. Atherosclerosis is a chronic inflammation that involves both innate and adaptive immunity. Glucocorticoids (GC) are immune-suppressors and adrenocorticotrophic hormone (ACTH) possesses immune-modulatory activities. GC and ACTH may act in atherothrombotic inflammatory pathways.Aim: To analyze the immune cells pattern in endogenous Cushing syndrome (CS) in order t...

ea0081ep106 | Adrenal and Cardiovascular Endocrinology | ECE2022

11-deoxycorticosterone producing adrenal hyperplasia as a very unusual cause of endocrine hypertension: case report and systematic review of the literature

Roca Queralt Asla , Simo Helena Sarda , Puertas Enrique Lerma , Hanzu Felicia Alexandra , Urgell Rull Eulalia , Perez Garcia Jose Ignacio , Youdale Susan Webb , Maso Ana Aulinas

11-deoxycorticosterone (DOC) is an aldosterone precursor synthesized from progesterone and converted to corticosterone in the adrenal cortex. DOC overproduction due to an adrenal lesion is a very rare cause of mineralocorticoid-induced hypertension. The objective of this study is to provide the most relevant clinical features that clinicians dealing with patients presenting with the hallmarks of hypertension due to DOC-producing adrenal lesions should be aware of. We report a ...

ea0090ep28 | Adrenal and Cardiovascular Endocrinology | ECE2023

Novel high resolution mass spectrometry profiling of free cortisol, cortisone, 6β- and 18-hydroxycortisol for the evaluation of glucocorticoid and mineralocorticoid disorders

Casals Gregori , Ballesteros Maria Antonieta , Zamora Angielys , Martinez Irene , Ruiz Montserrat , Fernandez-Varo Guillermo , Mora Mireia , Morales-Ruiz Manuel , Hanzu Felicia A

Introduction: Urine free cortisol measurements are routinely performed to evaluate hypercortisolism. Despite their analytical inaccuracy, immunoassay-based methods are frequently used. Advances in liquid chromatography high resolution mass spectrometry (LC-HRMS) facilitate the incorporation of powerful diagnostic tools into clinical laboratories with high analytical specificity that also allow simultaneous quantification of different metabolites and untargeted compound identif...

ea0063gp106 | Adrenal and Neuroendocrine - Basic | ECE2019

Gene expression changes in visceral adipose tissue of Cushing syndrome.

Garcia-Eguren Guillermo , Gonzalez Mar , Blanco Enrique , Giro Oriol , Vidal Oscar , Carmona Francesc , Casals Gregori , Mora Mireia , Halperin Irene , diCroce Luciano , Hanzu Felicia A

Introduction: Visceral adipose tissue (VAT) is the key target tissue of glucocorticoids (GC) during active Cushing Syndrome (CS) and a metabolic tissue associated to insulin-resistance and an increased cardiometabolic risk. Till date there are no data regarding gene expression in VAT in CS and only few data about the mRNA in subcutaneous one. The aim of this study was to study the visceral VAT tissue transcriptional changes in ACTH-independent CS.Methods...

ea0049gp24 | Adrenal 3 | ECE2017

Increased exosomes in endogeneous Cushing syndrome

Aranda Gloria , Xifra Gemma , Fernandez-Real Jose Manuel , Garcia-Eguren Guillermo , Casals Gregori , Pane Adriana , Mora Mireia , Halperin Irene , Hanzu Felicia A

Exosomes are nano-sized vesicles secreted by the cells in the exatracellular fluids representing a novel way of intracellular communication. Exosomes secreted from blood cells like monocytes and platetes have been reported to be checkpoints involved in haemostatic and thrombotic response. Glucocorticoids are inducing a profound alteration of blood cells homeostasis with atherothrombotic, bleeding and immune response alterations. Hereby we quantified for the first time circulat...

ea0041gp124 | Neuroendocrinology | ECE2016

Endothelial damage and thrombotic response in patients with cured Cushing syndrome

Aranda Velazquez Gloria , Mora Porta Mireia , Halperin Irene , Fernandez Rebeca , Diaz-Ricart Maribel , Palomo Marta , Vidal Oscar , Ensenat Joaquim , Casals Gregori , Alexandra Hanzu Felicia

Introduction: Clinical observational studies have reported the persistence of a high cardiovascular risk in patients with cured Cushing’s syndrome (CCS) compared with controls of the same age, gender and BMI. It is still at debated whether this is due to the persistence of comorbidities, hormone deficiencies or chronic changes induced by hypercortisolism. The aim of this translational approach was to investigate the interplay in CCS of the cardiovascular disease in vivo a...